A multicenter, randomized phase III study on neurotoxicity, safety and efficacy of weekly Pacilitaxel infused over 1-h vs. 3-h in patients with advanced solid tumors

S. Mielke; K. Mross; TA Gerds; A. Schmidt; W. Lange; D. Behringer

A multicenter, randomized phase III study on neurotoxicity, safety and efficacy of weekly Pacilitaxel infused over 1-h vs. 3-h in patients with advanced solid tumors

S. Mielke, K. Mross, TA Gerds, A. Schmidt, W. Lange, D. Behringer

Originalsprog	Udefineret/Ukendt
Tidsskrift	European Journal of Cancer Supplements
Vol/bind	1
Udgave nummer	5
Sider (fra-til)	S164
Status	Udgivet - 2003

Citationsformater

@article{f0d957ba282940ac8ccad7a380ae9422,

title = "A multicenter, randomized phase III study on neurotoxicity, safety and efficacy of weekly Pacilitaxel infused over 1-h vs. 3-h in patients with advanced solid tumors",

author = "S. Mielke and K. Mross and TA Gerds and A. Schmidt and W. Lange and D. Behringer",

year = "2003",

language = "Udefineret/Ukendt",

volume = "1",

pages = "S164",

journal = "European Journal of Cancer Supplements",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - A multicenter, randomized phase III study on neurotoxicity, safety and efficacy of weekly Pacilitaxel infused over 1-h vs. 3-h in patients with advanced solid tumors

AU - Mielke, S.

AU - Mross, K.

AU - Gerds, TA

AU - Schmidt, A.

AU - Lange, W.

AU - Behringer, D.

PY - 2003

Y1 - 2003

M3 - Tidsskriftartikel

VL - 1

SP - S164

JO - European Journal of Cancer Supplements

JF - European Journal of Cancer Supplements

IS - 5

ER -